137 related articles for article (PubMed ID: 34323697)
1. LncRNA DiGeorge syndrome critical region gene 5: A crucial regulator in malignant tumors.
Xia H; Huang Z; Liu S; Zhao X; He R; Wang Z; Shi W; Chen W; Li Z; Yu L; Huang P; Kang P; Su Z; Xu Y; Yam JWP; Cui Y
Biomed Pharmacother; 2021 Sep; 141():111889. PubMed ID: 34323697
[TBL] [Abstract][Full Text] [Related]
2. Propofol exerts anticancer activity on hepatocellular carcinoma cells by raising lncRNA DGCR5.
Sun Y; Sun H
J Cell Physiol; 2020 Mar; 235(3):2963-2972. PubMed ID: 31538334
[TBL] [Abstract][Full Text] [Related]
3. LncRNA DGCR5 promotes lung adenocarcinoma (LUAD) progression via inhibiting hsa-mir-22-3p.
Dong HX; Wang R; Jin XY; Zeng J; Pan J
J Cell Physiol; 2018 May; 233(5):4126-4136. PubMed ID: 29030962
[TBL] [Abstract][Full Text] [Related]
4. The role of long noncoding RNA DGCR5 in cancers: Focus on molecular targets.
Al-Hawary SIS; Rodrigues P; Bangali H; Hassan ZF; Elawady A
Cell Biochem Funct; 2024 Mar; 42(2):e3949. PubMed ID: 38379219
[TBL] [Abstract][Full Text] [Related]
5. LncRNA DGCR5 represses the development of hepatocellular carcinoma by targeting the miR-346/KLF14 axis.
Wang YG; Liu J; Shi M; Chen FX
J Cell Physiol; 2018 Jan; 234(1):572-580. PubMed ID: 30216442
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA DGCR5 represses hepatocellular carcinoma progression by inactivating Wnt signaling pathway.
Wang XL; Shi M; Xiang T; Bu YZ
J Cell Biochem; 2019 Jan; 120(1):275-282. PubMed ID: 30230592
[TBL] [Abstract][Full Text] [Related]
7. Downregulated Long Noncoding RNA DGCR5 Acts as a New Promising Biomarker for the Diagnosis and Prognosis of Ovarian Cancer.
Chen H; Tian X; Luan Y; Lu H
Technol Cancer Res Treat; 2019; 18():1533033819896809. PubMed ID: 31868103
[TBL] [Abstract][Full Text] [Related]
8. LncRNA DGCR5 promotes non-small cell lung cancer progression via sponging miR-218-5p.
Wang J; Shu HZ; Xu CY; Guo SG
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9947-9954. PubMed ID: 31799664
[TBL] [Abstract][Full Text] [Related]
9. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
10. Progress and assessment of lncRNA DGCR5 in malignant phenotype and immune infiltration of human cancers.
Xue C; Chen C; Gu X; Li L
Am J Cancer Res; 2021; 11(1):1-13. PubMed ID: 33520356
[TBL] [Abstract][Full Text] [Related]
11. Silencing lncRNA-DGCR5 increased trophoblast cell migration, invasion and tube formation, and inhibited cell apoptosis via targeting miR-454-3p/GADD45A axis.
Yang Y; Shang H
Mol Cell Biochem; 2021 Sep; 476(9):3407-3421. PubMed ID: 33973132
[TBL] [Abstract][Full Text] [Related]
12. PCAT-1: A pivotal oncogenic long non-coding RNA in human cancers.
Yang Z; Zhao S; Zhou X; Zhao H; Jiang X
Biomed Pharmacother; 2019 Feb; 110():493-499. PubMed ID: 30530229
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA DGCR5 involves in tumorigenesis of esophageal squamous cell carcinoma via SRSF1-mediated alternative splicing of Mcl-1.
Duan Y; Jia Y; Wang J; Liu T; Cheng Z; Sang M; Lv W; Qin J; Liu L
Cell Death Dis; 2021 Jun; 12(6):587. PubMed ID: 34099633
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA DGCR5 incudes tumorigenesis of triple-negative breast cancer by affecting Wnt/β-catenin signaling pathway.
Jiang D; Wang C; He J
J BUON; 2020; 25(2):702-708. PubMed ID: 32521856
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA DGCR5 suppresses gastric cancer progression by acting as a competing endogenous RNA of PTEN and BTG1.
Xu Y; Zhang G; Zou C; Gong Z; Wang S; Liu J; Ma G; Liu X; Zhang W; Jiang P
J Cell Physiol; 2019 Jul; 234(7):11999-12010. PubMed ID: 30515803
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of lncRNA DGCR5 correlates with better prognosis and inhibits bladder cancer progression via transcriptionally facilitating P21 expression.
Fang C; He W; Xu T; Dai J; Xu L; Sun F
J Cell Physiol; 2019 May; 234(5):6254-6262. PubMed ID: 30238982
[TBL] [Abstract][Full Text] [Related]
17. Critical Functions of lncRNA DGCR5 in Cancers of the Digestive System.
Hu C; Xu W; Wang B; Chen J; Zhou Z; Zhou G; Yuan C
Curr Pharm Des; 2021; 27(40):4147-4151. PubMed ID: 34387158
[TBL] [Abstract][Full Text] [Related]
18. DGCR5 promotes cancer stem cell-like properties of radioresistant laryngeal carcinoma cells by sponging miR-506 via Wnt pathway.
Tang T; Shan G
J Cell Physiol; 2019 Aug; 234(10):18423-18431. PubMed ID: 30980388
[TBL] [Abstract][Full Text] [Related]
19. lncRNA DGCR 5/miR‑27a‑3p/BNIP3 promotes cell apoptosis in pancreatic cancer by regulating the p38 MAPK pathway.
Li X; Zhou S; Fan T; Feng X
Int J Mol Med; 2020 Aug; 46(2):729-739. PubMed ID: 32626951
[TBL] [Abstract][Full Text] [Related]
20. DGCR5 suppresses the EMT of pediatric primary glioblastoma multiforme cell and serves as a prognostic biomarker.
Yang F; Huang YL
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):10024-10034. PubMed ID: 31799672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
